BOESS CARSTEN
Insider CIK 1277495 · ITEK Director · RNA Director · KNSA 10% owner · RNA Director · GEVA SVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2026-06-18 | 2026-07-06 | 64,860 | — | $0 | 64,860 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2026-06-18 | 2026-07-06 | 22,862 | — | $0 | 52,862 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 20,858 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,489 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 10,034 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 6,692 | — | $0 | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-06-18 | 2025-07-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 13,489 | — | $0 | 13,489 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-06-13 | 2024-06-20 | 23,944 | — | $0 | 23,944 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-06-22 | 2023-06-26 | 25,850 | — | $0 | 25,850 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-06-13 | 2022-06-15 | 47,745 | — | $0 | 47,745 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-06-16 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-06-14 | 2021-06-16 | 12,236 | — | $0 | 12,236 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2020-06-16 | 2020-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2019-01-28 | 2019-01-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 107,050 | — | $0 | 473,035 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 107,050 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 79,589 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2018-03-29 | 2018-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy deriv | 2018-02-09 | 2018-05-29 | 6,392 | $15.64 | $100.0K | 6,392 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2017-06-20 | 2017-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2016-06-23 | 2016-06-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2016-01-11 | 2016-01-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,292 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 9,929 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 15,938 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 45,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 24,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-05 | 2015-06-09 | 24,000 | — | $0 | 24,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-02-17 | 2015-02-19 | 13,235 | — | $0 | 9,929 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-02-17 | 2015-02-19 | 29,062 | — | $0 | 15,938 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-02-17 | 2015-02-19 | 13,235 | $1.70 | $22.5K | 13,235 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-02-17 | 2015-02-19 | 29,062 | $40.74 | $1.18M | 42,297 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-02-17 | 2015-02-19 | 8,989 | $98.85 | $888.6K | 33,308 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-02-17 | 2015-02-19 | 14,750 | $99.97 | $1.47M | 18,558 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-02-17 | 2015-02-19 | 16,716 | $100.74 | $1.68M | 1,842 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-02-17 | 2015-02-19 | 1,842 | $101.69 | $187.3K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-10-30 | 2014-10-30 | 7,854 | — | $0 | 7,292 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-10-30 | 2014-10-30 | 15,050 | — | $0 | 23,164 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-10-30 | 2014-10-30 | 15,050 | $1.70 | $25.6K | 15,050 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-10-30 | 2014-10-30 | 22,904 | $80.11 | $1.83M | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-10-30 | 2014-10-30 | 7,854 | $23.00 | $180.6K | 22,904 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-10-28 | 2014-10-30 | 1,000 | — | $0 | 15,146 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-10-28 | 2014-10-30 | 1,500 | — | $0 | 38,214 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-10-28 | 2014-10-30 | 1,500 | $80.00 | $120.0K | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-10-28 | 2014-10-30 | 1,000 | $23.00 | $23.0K | 2,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-10-28 | 2014-10-30 | 1,500 | $1.70 | $2.5K | 1,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-10-28 | 2014-10-30 | 1,000 | $80.00 | $80.0K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-05-16 | 2014-05-20 | 9,927 | — | $0 | 39,714 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-05-16 | 2014-05-20 | 9,927 | $1.70 | $16.9K | 9,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-05-16 | 2014-05-20 | 1,591 | $82.71 | $131.6K | 200 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-05-16 | 2014-05-20 | 8,136 | $81.75 | $665.1K | 1,791 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-05-16 | 2014-05-20 | 200 | $83.46 | $16.7K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-02-18 | 2014-02-20 | 9,927 | — | $0 | 49,641 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-02-18 | 2014-02-20 | 1,000 | $100.07 | $100.1K | 8,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-02-18 | 2014-02-20 | 9,927 | $1.70 | $16.9K | 9,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-02-18 | 2014-02-20 | 894 | $104.22 | $93.2K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-02-18 | 2014-02-20 | 1,745 | $103.05 | $179.8K | 894 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-02-18 | 2014-02-20 | 3,207 | $102.18 | $327.7K | 2,639 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-02-18 | 2014-02-20 | 3,081 | $101.14 | $311.6K | 5,846 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-11-18 | 2013-11-20 | 9,927 | — | $0 | 59,568 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-18 | 2013-11-20 | 500 | $57.20 | $28.6K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-18 | 2013-11-20 | 3,861 | $53.98 | $208.4K | 6,066 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-18 | 2013-11-20 | 1,765 | $54.97 | $97.0K | 4,301 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-11-18 | 2013-11-20 | 9,927 | $1.70 | $16.9K | 9,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-18 | 2013-11-20 | 3,801 | $55.99 | $212.8K | 500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-08-21 | 2013-08-22 | 6,681 | — | $0 | 16,146 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-08-21 | 2013-08-22 | 6,681 | $23.00 | $153.7K | 6,681 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-08-21 | 2013-08-22 | 6,681 | $47.19 | $315.3K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-08-20 | 2013-08-22 | 2,173 | — | $0 | 22,827 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-08-20 | 2013-08-22 | 5,627 | — | $0 | 69,495 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-08-20 | 2013-08-22 | 2,173 | $23.00 | $50.0K | 7,800 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-08-20 | 2013-08-22 | 7,800 | $47.04 | $366.9K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-08-20 | 2013-08-22 | 5,627 | $1.70 | $9.6K | 5,627 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-08-16 | 2013-08-20 | 4,300 | — | $0 | 75,122 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-08-16 | 2013-08-20 | 4,300 | $1.70 | $7.3K | 4,300 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-08-16 | 2013-08-20 | 4,300 | $47.47 | $204.1K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-07-11 | 2013-07-15 | 13,237 | — | $0 | 79,422 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-07-11 | 2013-07-15 | 13,237 | $1.70 | $22.5K | 13,237 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-07-11 | 2013-07-15 | 13,237 | $47.06 | $622.9K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-01-16 | 2013-01-18 | 9,927 | — | $0 | 92,659 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-01-16 | 2013-01-18 | 9,927 | $49.12 | $487.6K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-01-16 | 2013-01-18 | 9,927 | $1.70 | $16.9K | 9,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-10-16 | 2012-10-18 | 9,927 | — | $0 | 102,586 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-10-16 | 2012-10-18 | 7,127 | $49.88 | $355.5K | 2,800 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-10-16 | 2012-10-18 | 1,900 | $50.58 | $96.1K | 900 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-10-16 | 2012-10-18 | 900 | $51.17 | $46.1K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-10-16 | 2012-10-18 | 9,927 | $1.70 | $16.9K | 9,927 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-07-18 | 2012-07-20 | 6,618 | — | $0 | 112,513 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-07-18 | 2012-07-20 | 6,618 | $1.70 | $11.3K | 6,618 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-07-18 | 2012-07-20 | 6,618 | $48.82 | $323.1K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-05-16 | 2012-05-18 | 39,709 | — | $0 | 119,131 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-05-16 | 2012-05-18 | 39,709 | $1.70 | $67.5K | 39,709 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-05-16 | 2012-05-18 | 28,137 | $38.16 | $1.07M | 11,572 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-05-16 | 2012-05-18 | 11,572 | $38.82 | $449.2K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 25,000 | — | $0 | 25,000 | SEC↗ |